News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
Yuksel Urun: Europe emphasized program implementation for patient and organization support
Photo from Yuksel Urun/X
Apr 26, 2024, 08:22

Yuksel Urun: Europe emphasized program implementation for patient and organization support

Yuksel Urun, Professor in Department of Medical Oncology at Ankara University School of Medicine, shared on X/Twitter:

”The IKCS: Europe emphasized patient advocacy, focusing on program implementation for patient and organization support—a critical step for improved healthcare. ”

Source: Yuksel Urun/X

 

Ankara University School of Medicine cancer healthcare IKCS IKCS Europe IKCS Europe 2024 OncoDaily Oncology Patient Advocacy Yüksel Ürün
Special Coverage
Blog
Nov 15, 2024, 21:44
Karen Humphreys won the Advocate of the Year from the Florida Society of Clinical Oncology - UF Health Cancer Center
Blog
Nov 15, 2024, 21:37
Margaret Foti: AACR Special Conference on Liquid Biopsy
Blog
Nov 15, 2024, 21:26
Johanna Joyce: An inspiring end to our Tumor Immunology and Immunotherapy
Blog
Nov 15, 2024, 21:21
Adjuvant immunotherapy in patients with resected GEJ cancer with high risk for recurrence
Blog
Nov 15, 2024, 21:09
Miriam Knoll: An in-person lung tumor board with Nagashree Seetharamu
Insight
Nov 15, 2024, 21:05
Get Ready for ESTRO2025 Pre-Meeting Courses
Insight
Nov 15, 2024, 21:03
Explore the latest in oncology at ESMOASIA24
Insight
Nov 15, 2024, 21:02
Robin Zon: Debate day 2 of COSA
Blog
Nov 15, 2024, 20:28
Long-Term Adverse Effects and Complications After Prostate Cancer Treatment
Blog
Nov 15, 2024, 19:31
What is proton beam therapy and how does it work - Atrium Health
Blog
Nov 15, 2024, 17:47
Nico Gagelmann: Current status and Future directions for CAR-T Therapy
Insight
Nov 15, 2024, 17:45
Osteopontin as a therapeutic target in Breast Cancer recurrence